Consistently, our data of the CRC cell lines showed that the rate of detecting mutations was 25–75% (including heterozygous genes and ADOs of the wild type allele) in KRAS, BRAF, and PIK3CA (Table 1, highlighted in grey). This evidence concerns the gene KRAS and colorectal carcinoma.